PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.
By P. Turecek, M. J. Bossard, Freddy Schoetens, I. Ivens. Journal of Pharmacy and Science, 2016
619 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/17394dc69d4c3fa835e0bc8af6359ff0b1f9cc04
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Lulu Cai
- Rehmat Islam
- Yangbao Miao
- Rongsheng Tong
- Hongmei Liu
- Yang Lei
- Leming Sun
- Sumin Tan
Citations in the corpus
- Smart nanoparticles for cancer therapy (2023, background): “291 The successful listing of pegylated liposome Doxil, the fi rst nanoparticle therapeutic drug, in 1995 proved the feasibility of this technology.”